Kelly Lee Schmeichel is a prominent inventor based in Cincinnati, OH (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of respiratory illnesses. With a total of 14 patents to her name, Schmeichel's work is recognized for its innovative approaches to health care.

Latest Patents

Among her latest patents is a composition and method useful for the treatment of respiratory illness. This patent discloses compositions that include phenylephrine, its free and addition salt forms, and mixtures thereof, either alone or in combination with other pharmaceutical actives. The compositions are characterized by a pH of about 2 to about 5 and are substantially free of aldehydes. Additionally, she has developed aptamers for personal health care applications. This patent describes an aptamer composition that includes oligonucleotides with a binding affinity for specific cellular membrane glycoproteins, aimed at reducing the binding of human rhinoviruses.

Career Highlights

Kelly Lee Schmeichel is currently employed at The Procter & Gamble Company, where she continues to innovate in the pharmaceutical sector. Her work has not only advanced treatment options but has also contributed to the understanding of respiratory illnesses.

Collaborations

Some of her notable coworkers include Kurt Franklin Trombley and Jay Robert Morosey, Jr. Their collaborative efforts have further enhanced the research and development of effective health care solutions.

Conclusion

Kelly Lee Schmeichel's contributions to the field of respiratory treatment through her innovative patents highlight her role as a leading inventor. Her work continues to impact the health care industry positively.

This text is generated by artificial intelligence and may not be accurate.